The IL-1 cytokines have not only been implicated in the development and progression of hematological malignancies, but have also been attributed with increased incidence [34,35], poor prognosis [36], rapid disease development [8] and high metastasis burden [7,8] in different solid tumor entities. The gene discussed is IL1B; the disease is hematologic disorder.